Taken together, these observations thus leave open the possibility that both CD133+/CD24- ependymal cells and GFAP+ type-B cells located in the SVZ are at the origin of GBM, and that both cell types can give rise to each other or share very similar characteristics, possibly depending on the micro-environmental context and type of transforming mutations. This evidence concerns the gene GFAP and glioblastoma.